# A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients

> **NCT04345692** · PHASE3 · TERMINATED · sponsor: **Queen's Medical Center** · enrollment: 17 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04345692
- **Lead sponsor:** Queen's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-26
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** RECOVERY Trial results - no efficacy
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345692, "A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04345692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*